ArticleCirculation reports2024

Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure.

Koichiro Fujisue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.